Brain-derived neurotrophic factor is increased in serum levels of patients with symptomatic dermographism
| dc.authorid | Bozkurt, Bulent/0000-0003-4764-3735; | |
| dc.contributor.author | Erpolat, Seval | |
| dc.contributor.author | Celik, Huseyin Tugrul | |
| dc.contributor.author | Bozkurt, Bulent | |
| dc.date.accessioned | 2025-10-24T18:10:02Z | |
| dc.date.available | 2025-10-24T18:10:02Z | |
| dc.date.issued | 2017 | |
| dc.department | Malatya Turgut Özal Üniversitesi | |
| dc.description.abstract | Introduction: Symptomatic dermographism (SD) is the most common form of physical urticaria. However, the role of neuroimmune mechanisms in SD is unclear. Aim: To investigate circulating levels of brain-derived neurotrophic factor (BDNF) in symptomatic dermographism. Material and methods: Thirty-two patients suffering from SD and 33 healthy subjects were included in the study. Serum BDNF levels were determined by a human enzyme-linked immunoassay (ELISA) kit. The serum C-reactive protein concentration and eosinophil counts in peripheral blood were evaluated. Results: The BDNF serum levels were detectable in both SD patients and healthy controls. The BDNF serum levels were significantly higher in patients with SD compared with healthy controls (p = 0.004). There was a positive but weak correlation between serum BDNF and CRP levels; it was not statistically significant (r = 0.211, p = 0.255). There was also a positive but weak correlation between serum BDNF and eosinophil counts; it was not statistically significant (r = 0.271, p = 0.141). Conclusions: The present study shows that BDNF is increased in the serum levels of patients with SD, suggesting a role for BDNF in the pathophysiology of this disorder. | |
| dc.identifier.doi | 10.5114/ada.2017.69315 | |
| dc.identifier.endpage | 349 | |
| dc.identifier.issn | 1642-395X | |
| dc.identifier.issue | 4 | |
| dc.identifier.pmid | 28951710 | |
| dc.identifier.scopus | 2-s2.0-85026665048 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 346 | |
| dc.identifier.uri | https://doi.org/10.5114/ada.2017.69315 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12899/3955 | |
| dc.identifier.volume | 34 | |
| dc.identifier.wos | WOS:000408254400010 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Termedia Publishing House Ltd | |
| dc.relation.ispartof | Postepy Dermatologii I Alergologii | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_20251023 | |
| dc.subject | symptomatic dermographism; brain-derived neurotrophic factor; neurotrophin | |
| dc.title | Brain-derived neurotrophic factor is increased in serum levels of patients with symptomatic dermographism | |
| dc.type | Article |












